[Federal Register Volume 67, Number 127 (Tuesday, July 2, 2002)]
[Notices]
[Page 44465]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-16588]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Science Advisory Board to the National Center for Toxicological 
Research; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting will be closed to the public.
    Name of Committee: Science Advisory Board (SAB) to the National 
Center for Toxicological Research (NCTR).
    General Function of the Committee: The Board advises the Director, 
NCTR, on establishing, implementing, and evaluating the research 
programs that assist the Commissioner of Food and Drugs in fulfilling 
his regulatory responsibilities. The Board provides an extra agency 
review in ensuring that the research programs at NCTR are 
scientifically sound and pertinent.
    Date and Time: The meeting will be held on August 8, 2002, from 1 
p.m. to 5 p.m. and August 9, 2002, from 8 a.m. to 1 p.m.
    Location: NCTR, Building 
[]12, 
Conference Center, 3900 NCTR Dr., Jefferson, AR 72079.
    Contact Person: Leonard M. Schechtman, NCTR (HFT-10), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-6696, 
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington, DC area), code 12559. Please call the 
Information Line for up-to-date information on this meeting.
    Agenda: The Board will be presented with a draft report on the 
evaluation of the Division of Chemistry. The draft report is the 
product of a site visit team that conducted an onsite review of the 
Division in January. Division staffers will provide a preliminary 
response to the issues raised and recommendations made. The NCTR 
Director will provide a Center update and discuss the development of 
five newly established centers of excellence at the NCTR. These are 
the: Functional Genomics Center, Structural Genomics Center, 
Toxicoinformatics Center, Hepatotoxicity Center, and Phototoxicity 
Center. The Directors of each of these Centers will provide a 
presentation on the development and future of their respective center. 
A proposal presented to the Board at the June 2001 meeting regarding 
the establishment of a subcommittee on scientific opportunities to 
improve regulatory science through collaborations with external 
stakeholders will be revisited. The Board will receive an update on 
activities of an existing subcommittee with a similar focus (Advisory 
Committee for Pharmaceutical Science, Nonclinical Studies 
Subcommittee).
    Procedure: On August 8, 2002, from 1 p.m. to 5 p.m., and August 9, 
2002, from 8 a.m. to 12 noon, the meeting is open to the public. 
Interested persons may present data, information, or views, orally or 
in writing, on issues pending before the committee. Written submissions 
may be made to the contact person by July 31, 2002. Oral presentations 
from the public will be scheduled between approximately 11 a.m. and 12 
noon, on August 9, 2002. Time allotted for each presentation may be 
limited. Those desiring to make formal oral presentations should notify 
the contact person before July 31, 2002, and submit a brief statement 
of the general nature of the evidence or arguments they wish to 
present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their 
presentation.
    Closed Committee Deliberations. On August 9, 2002, from 12 noon to 
1 p.m., the meeting will be closed to permit discussion where 
disclosure would constitute a clearly unwarranted invasion of personal 
privacy (5 U.S.C. 552b(c)(6)). This portion of the meeting will be 
closed to permit discussion of information concerning individuals 
associated with the research programs at NCTR.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Leonard M. 
Schechtman at least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: June 24, 2002.
William K. Hubbard,
Senior Associate Commissioner for Policy, Planning, and Legislation.
[FR Doc. 02-16588 Filed 7-1-02; 8:45 am]
BILLING CODE 4160-01-S